NASHVILLE, Tenn.--(BUSINESS WIRE)--When breast cancer advances, the patient doesn’t have the luxury of time. Finding the right type of chemotherapy as quickly as possible is a critical factor for the patient’s success and, until now, predicting the patient’s sensitivity to chemotherapy has often been a shot in the dark.
